住院老年人院内药物不良反应:患病率、表现及相关药物的系统综述与荟萃分析
该系统综述与荟萃分析检索至2020年3月,纳入27项研究(29篇论文),涉及20,153例平均年龄≥65岁的住院老年患者,其中2,479例发生至少一次药物不良反应(ADR)。汇总ADR患病率为16%(95%CI 12-22%),近48.3%的ADR涉及五种临床表现,四类药物占致病药物的57.8%,四项研究报告多数ADR可预防(55-95%)。
要点
- 住院老年患者汇总ADR患病率为16%(95%CI 12-22%)。
- 五种临床表现占近48.3%:液体/电解质紊乱、胃肠动力/排便障碍、肾脏疾病、低血压/血压调节障碍/休克、谵妄。
- 四类药物占致病药物57.8%:利尿剂、抗菌药、抗血栓药、镇痛药。
核心结论
- 平均16%的住院老年患者发生显著ADR,严重程度不一,多数可预防。
- 常用处方药物类别导致了大多数ADR。
研究设计与样本
- 系统检索PubMed、Embase、EBSCO-CINAHL、Cochrane Library、灰色文献及相关系统综述参考文献,检索至2020年3月。
- 纳入报告住院老年(平均年龄≥65岁)院内ADR作为主要或次要结局的任何研究。
- 从2,399篇摘要中全文筛选286篇,最终纳入27项研究(29篇论文)。
- 汇总分析纳入20,153例住院老年患者,其中2,479例发生至少一次ADR。
- 采用随机效应荟萃分析模型合并研究估计值。
主要发现
- 汇总ADR患病率为16%(95%CI 12-22%,I2 98%,τ2 0.8585)。
- ADR判定方法高度异质。
- 近48.3%的ADR涉及五种临床表现:液体/电解质紊乱(17.3%)、胃肠动力/排便障碍(13.3%)、肾脏疾病(8.2%)、低血压/血压调节障碍/休克(5.5%)、谵妄(4.1%)。
- 四类药物占致病药物的57.8%:利尿剂(19.8%)、抗菌药(14.8%)、抗血栓药(12.2%)、镇痛药(10.9%)。
- 四项研究报告多数ADR可预防(55-95%)。
关键数值与推荐
- 纳入标准:平均年龄≥65岁的住院患者,报告院内ADR发生作为主要或次要结局。
- 汇总ADR患病率16%(95%CI 12-22%)。
- 五种主要临床表现及占比:液体/电解质紊乱17.3%、胃肠动力/排便障碍13.3%、肾脏疾病8.2%、低血压/血压调节障碍/休克5.5%、谵妄4.1%。
- 四类主要致病药物及占比:利尿剂19.8%、抗菌药14.8%、抗血栓药12.2%、镇痛药10.9%。
- 四项研究报告可预防ADR比例为55-95%。
临床怎么用
- 对住院老年患者应警惕利尿剂、抗菌药、抗血栓药和镇痛药相关ADR。
- 关注液体/电解质紊乱、胃肠动力/排便障碍、肾脏疾病、低血压/休克和谵妄等ADR表现。
- 鉴于多数ADR可预防,应加强用药监测与预防措施。
局限性
- ADR判定方法高度异质。
- 严重程度的汇总分析不可行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: the prevalence of adverse drug reactions (ADRs) in hospitalised older patients, their clinical presentations, causative drugs, severity, preventability and measurable outcomes are unclear, ADRs being an increasing challenge to older patient safety. METHODS: we systematically searched PubMed, Embase, EBSCO-CINAHL, the Cochrane Library, 'rey' literature and relevant systematic review bibliographies, published from database inception to March 2020. We included any study reporting occurrence of in-hospital ADRs as primary or secondary outcomes in hospitalised older adults (mean age ≥ 65 years). Two authors independently extracted relevant information and appraised studies for bias. Study characteristics, ADR clinical presentations, causative drugs, severity, preventability and clinical outcomes were analysed. Study estimates were pooled using random-effects meta-analytic models. RESULTS: from 2,399 abstracts, we undertook full-text screening in 286, identifying 27 studies (29 papers). Final analysis yielded a pooled ADR prevalence of 16% (95%CI 12-22%, I2 98%,τ2 0.8585), in a population of 20,153 hospitalised patients aged ≥65 years of whom 2,479 patients experienced ≥ one ADR. ADR ascertainment was highly heterogeneous. Almost 48.3% of all ADRs involved five presentations: fluid/electrolyte disturbances (17.3%), gastrointestinal motility/defaecation disorders (13.3%), renal disorders (8.2%), hypotension/blood pressure dysregulation disorders/shock (5.5%) and delirium (4.1%). Four drug classes accounted for 57.8% of causative medications i.e. diuretics (19.8%), anti-bacterials (14.8%), antithrombotic agents (12.2%) and analgesics (10.9%). Pooled analysis of severity was not feasible. Four studies reported the majority of ADRs as preventable (55-95%). CONCLUSIONS: on average, 16% of hospitalised older patients experience significant ADRs, varying in severity and mostly preventable, with commonly prescribed drug classes accounting for most ADRs.
引用
- Jennings ELM, Murphy KD, Gallagher P, et al. In-hospital adverse drug reactions in older adults; prevalence, presentation and associated drugs-a systematic review and meta-analysis. Age Ageing. 2020. PMID: 33022061. doi:10.1093/ageing/afaa188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。